Defining a Schistosomiasis Vaccination Strategy – Is it really Th1 versus Th2?
- 1 November 2000
- journal article
- review article
- Published by Elsevier in Parasitology Today
- Vol. 16 (11) , 497-501
- https://doi.org/10.1016/s0169-4758(00)01788-9
Abstract
No abstract availableKeywords
This publication has 40 references indexed in Scilit:
- Early Interleukin–4: Its Role in the Switch towards a Th2 Response and IgE–Mediated AllergyInternational Archives of Allergy and Immunology, 1999
- The debate over the effector function of eosinophils in helminth infection: new evidence from studies on the regulation of vaccine immunity by IL-12Memórias do Instituto Oswaldo Cruz, 1997
- Functional diversity of helper T lymphocytesNature, 1996
- Development of a vaccine strategy against human and bovine schistosomiasis: background and updateMemórias do Instituto Oswaldo Cruz, 1995
- Regulation and biological function of helminth-induced cytokine responsesImmunology Today, 1991
- Acquired immunity and epidemiology of Schistosoma haematobiumNature, 1991
- Human IgE, IgG4 and resistance to reinfection with Schistosoma haematobiumNature, 1991
- Antibody to Interleukin-5 Inhibits Helminth-Induced Eosinophilia in MiceScience, 1989
- TH1 and TH2 Cells: Different Patterns of Lymphokine Secretion Lead to Different Functional PropertiesAnnual Review of Immunology, 1989
- Interleukin 4 causes isotype switching to IgE in T cell-stimulated clonal B cell cultures.The Journal of Experimental Medicine, 1988